Supplementary Table 2 from Impact of TP53 Mutations on Outcome in EGFR-Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors
Autor: | Paola Ulivi, Dino Amadori, Lucio Crinò, Vienna Ludovini, Daniele Calistri, Chiara Bennati, Rita Chiari, Alessandro Gamboni, Marita Mariotti, Nicoletta De Luigi, Claudia Casanova, Laura Capelli, Maximilian Papi, Claudio Dazzi, Elisa Chiadini, Angelo Delmonte, Elisabetta Petracci, Matteo Canale |
---|---|
Rok vydání: | 2023 |
Popis: | Relation of TP53 mutations and clinical characteristics of patients |
Databáze: | OpenAIRE |
Externí odkaz: |